Professional roles of general practitioners, community pharmacists and specialist providers in collaborative medication deprescribing - a qualitative study

Abstract

Background: Collaborative care approaches between general practitioners (GPs) and pharmacists have received international recognition for medication optimization and deprescribing efforts. Although specialist providers have been shown to influence deprescribing, their profession so far remains omitted from collaborative care approaches for medication optimization. Similarly, while explorative studies on role perception and collaboration between GPs and pharmacists grow, interaction with specialists for medication optimization is neglected. Our qualitative study therefore aims to explore GPs', community pharmacists' and specialist providers' role perceptions of deprescribing, and to identify interpersonal as well as structural factors that may influence collaborative medication optimization approaches. Method: Seven focus-group discussions with GPs, community pharmacists and community specialists were conducted in Hesse and Lower Saxony, Germany. The topic guide focused on views and experiences with deprescribing with special attention to inter-professional collaboration. We conducted conventional content analysis and conceptualized emerging themes using the Theoretical Domains Framework. Results: Twenty-six GPs, four community pharmacists and three community specialists took part in the study. The main themes corresponded to the four domains 'Social/professional role and identity' (1), 'Social influences' (2), 'Reinforcement' (3) and´Environmental context and resources' (4) which were further described by beliefs statements, that is inductively developed key messages. For (1), GPs emerged as central medication managers while pharmacists and specialists were assigned confined or subordinated tasks in deprescribing. Social influences (2) encompassed patients' trust in GPs as a support, while specialists and pharmacists were believed to threaten GPs' role and deprescribing attempts. Reinforcements (3) negatively affected GPs' and pharmacists' effort in medication optimization by social reprimand and lacking reward. Environmental context (4) impeded deprescribing efforts by deficient reimbursement and resources as well as fragmentation of care, while informational and gate-keeping resources remained underutilized.

Practices among General Practitioners in Rheumatoid Arthritis (GEPRA-I): results of a region-wide online survey

“…In other diseases, models of collaboration in primary care are being developed [ 25 ]. Several studies have showed the recognition of pharmacist and GP roles in collaborative care approaches [ 26 , 27 ]. Once the barriers between pharmacists and GPs were addressed, collaborations were linked to improved patient outcomes [ 28 , 29 ].…”

“…In the context of an increasing burden on primary healthcare services, effective multidisciplinary collaboration is crucial for sustaining high quality care [ 23 ]. Nevertheless, interaction with specialists for therapeutic optimisation should not be neglected in order to obtain a transparent continuity of care [ 27 ].…”

Development and Validation of Comprehensive Healthcare Providers’ Opinions, Preferences, and Attitudes towards Deprescribing (CHOPPED Questionnaire)

“…For item development, both deductive and inductive methods were used [ 16 ]. An extensive literature examination was performed, including qualitative design studies, commentaries, letters to the editors, expert opinions, and systematic reviews on the topic, in order to identify key concepts, themes, and factors [ 9 , 14 , 15 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 ]. Authors identified three frequently appearing themes: patient, profession, and organisation.…”

Less is More: Deprescribing Medications in Older Adults with Kidney Disease: A Review

“…Clinician barriers also include managing alternate goals during the patient encounter (e.g., achieving glycemic goals to meet a metric or guideline), challenges communicating with other clinical team members, inadequate time and training on how to approach deprescribing, and a lack of clear evidence-based guidelines 85,86 . Conflicts between the role of the pharmacist, primary care physician, and specialists may also impair deprescribing ---and this may be especially challenging if there is not an interoperable electronic health record (EHR) for communicating questions or concerns regarding medications 81,85 .…”